Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.Journal of clinical epidemiology · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprisebioRxiv · 2026-08-25Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female ParticipantsbioRxiv · 2026-08-19Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10The "dark magic mushroom" co-produces amatoxins and psilocybin.bioRxiv: the preprint server for biology · 2026-07-22Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.Molecular psychiatry · 2026-07-16Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-07-01Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health.Addictive behaviors · 2026-06-01Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.Schizophrenia research · 2026-06-01Serotonergic Polypharmacology of 2-Halogenated Tryptamines.bioRxiv: the preprint server for biology · 2026-04-21Reshaping human neurons.eLife · 2026-03-31Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.bioRxiv: the preprint server for biology · 2026-03-23Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-04Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-ExchangeJournal of the American Society for Mass Spectrometry · 2026-02-04Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.Brain and behavior · 2026-02-01Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.Journal of physiology and pharmacology: an official journal of the Polish Physiological Society · 2026-02-01Snapshot IP Detection Following 5-HTA Receptor Stimulation in the Mouse Brain.ACS chemical neuroscience · 2026-01-21Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.Journal of psychopharmacology (Oxford, England) · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.Frontiers in pharmacology · 2026-01-01Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.The European journal of neuroscience · 2025-12-01Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Psilocybin Experiential Therapist Training: Insights from a World-First StudymedRxiv · 2025-11-17Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.Neuropharmacology · 2025-11-15Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.Palliative & supportive care · 2025-10-23Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERSThe international journal of neuropsychopharmacology · 2025-08-01Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybinbioRxiv · 2025-05-30IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.Pharmacological research · 2025-05-01Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.Translational psychiatry · 2025-03-25The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-21Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.European journal of pharmacology · 2025-03-15Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.Journal of affective disorders · 2025-02-01Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.Current psychiatry reports · 2025-02-01Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.The American journal of psychiatry · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder.PloS one · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2025-01-01Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-22Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybinbioRxiv · 2024-12-13Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.Journal of the American Academy of Child and Adolescent Psychiatry · 2024-12-01Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2024-12-01Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.Psychedelic medicine (New Rochelle, N.Y.) · 2024-12-01Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.Nature. Mental health · 2024-11-01Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.PsyArXiv · 2024-10-18Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.PsyArXiv · 2024-10-18Snapshot of 5-HT receptor activation in the mouse brain via IP detection.bioRxiv: the preprint server for biology · 2024-10-12Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01Beyond the numbers: reimagining healing with psychedelics for eating disorders.Journal of eating disorders · 2024-09-30Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.Scientific reports · 2024-07-17Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.Naunyn-Schmiedeberg's archives of pharmacology · 2024-05-01300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot studyJournal of clinical and translational science · 2024-04-24Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.Scientific reports · 2024-04-17Psilocybin induces dose-dependent changes in functional network organization in rat cortex.bioRxiv: the preprint server for biology · 2024-02-15Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.Scientific reports · 2024-02-07Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.Frontiers in psychiatry · 2024-01-01Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.Current biology: CB · 2023-12-18Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.Addictive behaviors reports · 2023-12-01Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.Journal of psychopharmacology (Oxford, England) · 2023-11-01Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.Research square · 2023-07-07Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-18Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.Neuropharmacology · 2023-03-01Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.Scientific reports · 2023-02-11Acute psilocybin enhances cognitive flexibility in rats.bioRxiv: the preprint server for biology · 2023-01-09Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.Frontiers in psychiatry · 2023-01-01Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests.Frontiers in psychiatry · 2023-01-01An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.Journal of psychoactive drugs · 2023-01-01Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.Scientific reports · 2022-12-19Manuel de Yale pour la Thérapie de la Dépression Assistée par la PsilocybinePsyArXiv · 2022-11-155-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in micebioRxiv · 2022-11-03Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.Neuroscience letters · 2022-09-25Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-08-01A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.Journal of analytical toxicology · 2022-07-14The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.Journal of psychopharmacology (Oxford, England) · 2022-07-01Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific reports · 2022-06-22Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.Psychopharmacology · 2022-06-01Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.Psychopharmacology · 2022-06-01Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic engineering communications · 2022-06-01Psilocybin-induced takotsubo cardiomyopathy.BMJ case reports · 2022-05-17Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Molecules (Basel, Switzerland) · 2022-04-14Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific reports · 2022-04-07Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.Journal of the neurological sciences · 2022-03-15Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.Journal of psychoactive drugs · 2022-01-01Lower-dose psycholytic therapy - A neglected approach.Frontiers in psychiatry · 2022-01-01Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.Pharmaceuticals (Basel, Switzerland) · 2021-11-24Psychedelics and Mindfulness: A Systematic Review and Meta-AnalysisPsyArXiv · 2021-10-11Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.The American journal of drug and alcohol abuse · 2021-07-04The Therapeutic Potential of Psilocybin.Molecules (Basel, Switzerland) · 2021-05-15Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS pharmacology & translational science · 2021-04-09Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2021-02-03What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.Porto biomedical journal · 2021-01-01The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.Journal of psychopharmacology (Oxford, England) · 2020-09-01The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)PsyArXiv · 2020-08-13Emotions and brain function are altered up to one month after a single high dose of psilocybin.Scientific reports · 2020-02-10Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.Journal of psychopharmacology (Oxford, England) · 2020-02-01Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-09-01Psychedelic-assisted therapies: The past, and the need to move forward responsibly.The International journal on drug policy · 2019-08-01Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.Current topics in behavioral neurosciences · 2018-01-01Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in pharmacology · 2018-01-01[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].L'Encephale · 2017-08-01[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Journal of psychopharmacology (Oxford, England) · 2015-03-01Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Neuroscience letters · 2013-03-01Animal models of serotonergic psychedelics.ACS chemical neuroscience · 2013-01-16Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.Neuroscience letters · 2011-04-15Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2011-02-02Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.The International journal on drug policy · 2010-11-01Agonist-trafficking and hallucinogens.Current medicinal chemistry · 2009-01-01Identification of a serotonin/glutamate receptor complex implicated in psychosis.Nature · 2008-03-06Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.Neuron · 2007-02-01Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.Planta medica · 2006-06-01Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.Journal of ethnopharmacology · 1994-07-08Extraction and analysis of indole derivatives from fungal biomass.Journal of basic microbiology · 1994-01-01Biotransformation of Tryptamine in Fruiting Mycelia of Psilocybe cubensis.Planta medica · 1989-06-01Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe.Journal of basic microbiology · 1989-01-01Variation of the Amount of Alkaloids in Fruit Bodies of Inocybe aeruginascens.Planta medica · 1987-12-01Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus.Planta medica · 1987-06-01Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.Lloydia · 1976-01-01